Squarepoint
REPL icon

Squarepoint’s Replimune Group REPL Stock Holding History

Squarepoint’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,800
Closed -$70.4K – 4777
2025
Q3 		$70.4K Buy
+16,800
New +$107K ﹤0.01% 4175

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Squarepoint's REPL Position: Q1 2026 in Review

Squarepoint sold out of Replimune Group (REPL) in Q1 2026, closing a stake of 67,271 shares — an estimated $654K sold.

Squarepoint first reported a position in REPL in Q2 2019 and held it in 21 quarters. The position peaked at $2.69M in Q4 2020. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Squarepoint reported no remaining Replimune Group position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 67,271 Replimune Group shares in Q1 2026, an estimated $654K.
  • Squarepoint first reported a position in Replimune Group in Q2 2019 and held it in 21 quarters.
  • Squarepoint's Replimune Group position peaked at $2.69M in Q4 2020.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.